Cellevate AB
www.cellevate.comCellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3d™ Microcarriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform for several applications, including next generation cell- and gene therapies. For more information, please visit www.cellevate.com
Read moreCellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3d™ Microcarriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform for several applications, including next generation cell- and gene therapies. For more information, please visit www.cellevate.com
Read moreCountry
City (Headquarters)
Lund
Industry
Employees
11-50
Founded
2014
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President Business Development
Email ****** @****.comPhone (***) ****-****Vice President Research and Development
Email ****** @****.comPhone (***) ****-****Founder
Email ****** @****.comPhone (***) ****-****Chief Business Officer
Email ****** @****.comPhone (***) ****-****